The Medicines Patent Pool (MPP) commends WHO’s continued leadership in health emergency response.
We would like to highlight the importance of initiatives that strengthen regional capacity to address emerging threats. Ensuring access to technology and know-how is essential for building resilient health systems capable of withstanding future crises. The mRNA Technology Transfer Programme, with partners across 15 low- and middle-income countries, exemplifies how equitable access to critical health technologies can be enhanced through collaboration. Sustained investment in R&D, technology sharing, and licensing models that ensure timely and affordable access to countermeasures will be crucial.
MPP remains committed to working alongside WHO, Member States, and partners to strengthen our collective capacity to respond to health emergencies.
Thank you!